アルモダフィニルの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3600)
◆英語タイトル:Global Armodafinil Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3600
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、アルモダフィニルの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(50mg錠、150mg錠、200mg錠、250mg錠)、用途別市場規模(閉塞性睡眠時無呼吸症候群(OSA)&ナルコレプシー、交代勤務障害(SWD)、重度肝障害患者、老年期患者)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・アルモダフィニルの市場動向
・企業の競争状況、市場シェア
・アルモダフィニルの種類別市場規模(50mg錠、150mg錠、200mg錠、250mg錠)
・アルモダフィニルの用途別市場規模(閉塞性睡眠時無呼吸症候群(OSA)&ナルコレプシー、交代勤務障害(SWD)、重度肝障害患者、老年期患者)
・アルモダフィニルの北米市場規模2016-2027(アメリカ、カナダ)
・アルモダフィニルの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・アルモダフィニルのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・アルモダフィニルの中南米市場規模2016-2027(メキシコ、ブラジル)
・アルモダフィニルの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Teva、Mylan、Apotex、Lupin、Sandoz、Natco Pharma、Aurobindo)
・結論
【レポートの概要】

Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil.

Market Analysis and Insights: Global Armodafinil Market
The global Armodafinil market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Armodafinil market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Armodafinil market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Armodafinil market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Armodafinil market.

Global Armodafinil Scope and Market Size
Armodafinil market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Armodafinil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
50 mg Tablets
150 mg Tablets
200 mg Tablets
250 mg Tablets

Segment by Application
Obstructive Sleep Apnea (OSA) and Narcolepsy
Shift Work Disorder (SWD)
Patients with Severe Hepatic Impairment
Geriatric Patients

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Mylan
Apotex
Lupin
Sandoz
Natco Pharma
Aurobindo

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Armodafinil Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 50 mg Tablets
1.2.3 150 mg Tablets
1.2.4 200 mg Tablets
1.2.5 250 mg Tablets
1.3 Market by Application
1.3.1 Global Armodafinil Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Obstructive Sleep Apnea (OSA) and Narcolepsy
1.3.3 Shift Work Disorder (SWD)
1.3.4 Patients with Severe Hepatic Impairment
1.3.5 Geriatric Patients
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Armodafinil Market Perspective (2016-2027)
2.2 Armodafinil Growth Trends by Regions
2.2.1 Armodafinil Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Armodafinil Historic Market Share by Regions (2016-2021)
2.2.3 Armodafinil Forecasted Market Size by Regions (2022-2027)
2.3 Armodafinil Industry Dynamic
2.3.1 Armodafinil Market Trends
2.3.2 Armodafinil Market Drivers
2.3.3 Armodafinil Market Challenges
2.3.4 Armodafinil Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Armodafinil Players by Revenue
3.1.1 Global Top Armodafinil Players by Revenue (2016-2021)
3.1.2 Global Armodafinil Revenue Market Share by Players (2016-2021)
3.2 Global Armodafinil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Armodafinil Revenue
3.4 Global Armodafinil Market Concentration Ratio
3.4.1 Global Armodafinil Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Armodafinil Revenue in 2020
3.5 Armodafinil Key Players Head office and Area Served
3.6 Key Players Armodafinil Product Solution and Service
3.7 Date of Enter into Armodafinil Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Armodafinil Breakdown Data by Type
4.1 Global Armodafinil Historic Market Size by Type (2016-2021)
4.2 Global Armodafinil Forecasted Market Size by Type (2022-2027)

5 Armodafinil Breakdown Data by Application
5.1 Global Armodafinil Historic Market Size by Application (2016-2021)
5.2 Global Armodafinil Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Armodafinil Market Size (2016-2027)
6.2 North America Armodafinil Market Size by Type
6.2.1 North America Armodafinil Market Size by Type (2016-2021)
6.2.2 North America Armodafinil Market Size by Type (2022-2027)
6.2.3 North America Armodafinil Market Size by Type (2016-2027)
6.3 North America Armodafinil Market Size by Application
6.3.1 North America Armodafinil Market Size by Application (2016-2021)
6.3.2 North America Armodafinil Market Size by Application (2022-2027)
6.3.3 North America Armodafinil Market Size by Application (2016-2027)
6.4 North America Armodafinil Market Size by Country
6.4.1 North America Armodafinil Market Size by Country (2016-2021)
6.4.2 North America Armodafinil Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Armodafinil Market Size (2016-2027)
7.2 Europe Armodafinil Market Size by Type
7.2.1 Europe Armodafinil Market Size by Type (2016-2021)
7.2.2 Europe Armodafinil Market Size by Type (2022-2027)
7.2.3 Europe Armodafinil Market Size by Type (2016-2027)
7.3 Europe Armodafinil Market Size by Application
7.3.1 Europe Armodafinil Market Size by Application (2016-2021)
7.3.2 Europe Armodafinil Market Size by Application (2022-2027)
7.3.3 Europe Armodafinil Market Size by Application (2016-2027)
7.4 Europe Armodafinil Market Size by Country
7.4.1 Europe Armodafinil Market Size by Country (2016-2021)
7.4.2 Europe Armodafinil Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Armodafinil Market Size (2016-2027)
8.2 Asia-Pacific Armodafinil Market Size by Type
8.2.1 Asia-Pacific Armodafinil Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Armodafinil Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Armodafinil Market Size by Type (2016-2027)
8.3 Asia-Pacific Armodafinil Market Size by Application
8.3.1 Asia-Pacific Armodafinil Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Armodafinil Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Armodafinil Market Size by Application (2016-2027)
8.4 Asia-Pacific Armodafinil Market Size by Region
8.4.1 Asia-Pacific Armodafinil Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Armodafinil Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Armodafinil Market Size (2016-2027)
9.2 Latin America Armodafinil Market Size by Type
9.2.1 Latin America Armodafinil Market Size by Type (2016-2021)
9.2.2 Latin America Armodafinil Market Size by Type (2022-2027)
9.2.3 Latin America Armodafinil Market Size by Type (2016-2027)
9.3 Latin America Armodafinil Market Size by Application
9.3.1 Latin America Armodafinil Market Size by Application (2016-2021)
9.3.2 Latin America Armodafinil Market Size by Application (2022-2027)
9.3.3 Latin America Armodafinil Market Size by Application (2016-2027)
9.4 Latin America Armodafinil Market Size by Country
9.4.1 Latin America Armodafinil Market Size by Country (2016-2021)
9.4.2 Latin America Armodafinil Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Armodafinil Market Size (2016-2027)
10.2 Middle East & Africa Armodafinil Market Size by Type
10.2.1 Middle East & Africa Armodafinil Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Armodafinil Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Armodafinil Market Size by Type (2016-2027)
10.3 Middle East & Africa Armodafinil Market Size by Application
10.3.1 Middle East & Africa Armodafinil Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Armodafinil Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Armodafinil Market Size by Application (2016-2027)
10.4 Middle East & Africa Armodafinil Market Size by Country
10.4.1 Middle East & Africa Armodafinil Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Armodafinil Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Armodafinil Introduction
11.1.4 Teva Revenue in Armodafinil Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Armodafinil Introduction
11.2.4 Mylan Revenue in Armodafinil Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 Apotex
11.3.1 Apotex Company Details
11.3.2 Apotex Business Overview
11.3.3 Apotex Armodafinil Introduction
11.3.4 Apotex Revenue in Armodafinil Business (2016-2021)
11.3.5 Apotex Recent Development
11.4 Lupin
11.4.1 Lupin Company Details
11.4.2 Lupin Business Overview
11.4.3 Lupin Armodafinil Introduction
11.4.4 Lupin Revenue in Armodafinil Business (2016-2021)
11.4.5 Lupin Recent Development
11.5 Sandoz
11.5.1 Sandoz Company Details
11.5.2 Sandoz Business Overview
11.5.3 Sandoz Armodafinil Introduction
11.5.4 Sandoz Revenue in Armodafinil Business (2016-2021)
11.5.5 Sandoz Recent Development
11.6 Natco Pharma
11.6.1 Natco Pharma Company Details
11.6.2 Natco Pharma Business Overview
11.6.3 Natco Pharma Armodafinil Introduction
11.6.4 Natco Pharma Revenue in Armodafinil Business (2016-2021)
11.6.5 Natco Pharma Recent Development
11.7 Aurobindo
11.7.1 Aurobindo Company Details
11.7.2 Aurobindo Business Overview
11.7.3 Aurobindo Armodafinil Introduction
11.7.4 Aurobindo Revenue in Armodafinil Business (2016-2021)
11.7.5 Aurobindo Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ アルモダフィニルの世界市場規模・現状・予測2021年-2027年(Global Armodafinil Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。